SILINGARDI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 5.491
EU - Europa 3.324
AS - Asia 1.190
SA - Sud America 52
AF - Africa 25
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.110
Nazione #
US - Stati Uniti d'America 5.439
IT - Italia 999
GB - Regno Unito 955
SE - Svezia 424
CN - Cina 305
SG - Singapore 284
DE - Germania 222
UA - Ucraina 221
TR - Turchia 205
HK - Hong Kong 173
FI - Finlandia 115
FR - Francia 102
RU - Federazione Russa 90
BG - Bulgaria 71
VN - Vietnam 45
ID - Indonesia 42
IN - India 41
BR - Brasile 34
CA - Canada 22
MY - Malesia 22
AU - Australia 20
NL - Olanda 20
BZ - Belize 19
RO - Romania 17
SA - Arabia Saudita 17
BE - Belgio 16
CZ - Repubblica Ceca 15
IR - Iran 15
IE - Irlanda 14
CH - Svizzera 8
ET - Etiopia 8
PK - Pakistan 8
ES - Italia 7
EU - Europa 7
CO - Colombia 6
LT - Lituania 6
PL - Polonia 6
JP - Giappone 5
KR - Corea 5
MX - Messico 5
CL - Cile 4
EE - Estonia 4
EG - Egitto 4
TW - Taiwan 4
ZA - Sudafrica 4
AR - Argentina 3
BD - Bangladesh 3
GE - Georgia 3
IQ - Iraq 3
KE - Kenya 3
TH - Thailandia 3
VE - Venezuela 3
AL - Albania 2
AN - Antille olandesi 2
AT - Austria 2
DZ - Algeria 2
LK - Sri Lanka 2
MK - Macedonia 2
PH - Filippine 2
PR - Porto Rico 2
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
EC - Ecuador 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
KG - Kirghizistan 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 10.110
Città #
Santa Clara 804
Southend 778
Fairfield 491
Chandler 455
Jacksonville 432
Woodbridge 320
Dearborn 318
Ashburn 300
Houston 238
Wilmington 221
Singapore 215
Nyköping 212
Ann Arbor 203
Cambridge 192
Hong Kong 162
Seattle 157
Izmir 112
Beijing 101
Princeton 86
San Diego 73
Eugene 71
Sofia 70
Des Moines 63
Milan 55
Rome 51
Helsinki 47
Dong Ket 44
Jakarta 42
Falls Church 39
Bremen 31
San Jose 31
Moscow 30
New York 28
Redwood City 21
Shanghai 20
Belize City 19
London 18
Modena 18
Norwalk 17
Brussels 16
Palermo 16
Naples 15
Brno 13
Buraidah 13
Saint Petersburg 13
San Mateo 13
Verona 13
Los Angeles 12
Saint Louis 12
Boardman 11
Nanjing 11
Ottawa 11
Kunming 10
Munich 10
Philadelphia 10
Dublin 9
Florence 9
Torino 9
Auburn Hills 8
Axum 8
Bologna 8
Brisbane 8
Dallas 8
Turin 8
Bari 7
Cagliari 7
Guangzhou 7
Hefei 7
Livorno 7
Padova 7
Toronto 7
Leawood 6
Perugia 6
Albuquerque 5
Boulder 5
Catania 5
Chicago 5
Chiswick 5
Columbus 5
Fuzhou 5
Indiana 5
Jinan 5
Las Vegas 5
Mountain View 5
Nanchang 5
Napoli 5
Pune 5
Venice 5
Washington 5
Wuhan 5
Atlanta 4
Austin 4
Gurupi 4
Imola 4
Islamabad 4
L'aquila 4
Monmouth Junction 4
Parma 4
Phoenix 4
Reggio Calabria 4
Totale 7.045
Nome #
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 655
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 392
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 385
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 244
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 239
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 233
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 217
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 215
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 196
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 189
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 184
Hodgkin's disease prognosis: a directly predictive equation 174
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 167
Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171) 167
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting 165
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 165
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL) 163
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 161
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 152
A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma 152
Bone marrow infiltration in Hairy cell leukemia after interferon therapy detected by magnetic resonance imagin 152
Screening clinico, mammografico e genetico del carcinoma mammario ereditario 149
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME 148
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS 148
Leucemia e tricoleucociti: studio clinico patologico di 30 casi 147
Trapianto di midollo osseo nelle aplasie midollari. 146
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL 145
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia 145
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 144
Detection of bone marrow involvement in patients with cancer 140
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 139
Studio clinico immunologico di sei casi di morbo di Behcet 133
Prevention of cisplatin induced vomiting in patients with cancer. A pilot study with a multiagent protocol 132
Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicenter study in non-splenectomized patients 130
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 128
Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study 128
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades 128
Profilassi del vomito nei pazienti affetti da linfoma non-Hodgkin trattati con il protocollo ProMECE-CytaBOM. Risultati preliminari di uno studio clinico controllato 126
Alimentazione e tumori III. Gli oligoelementi 125
Alimentazione e tumori II. Le vitamine 123
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety 123
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin 123
Hereditary risk of breast cancer: not only brca 121
Istiocitosi maligna 121
Alimentazione e tumori I. Considerazioni dietetiche generali: gli alimenti 121
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 119
Usefulness of breast MRI in a patient with genetic risk 119
Utilità della Risonanza Magnetica Nucleare nello studio del midollo osseo di pazienti affetti da hairy Cell Leukemia 118
Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL 117
The excretion of tryptophan metabolites in patients with different forms of haemoblastosis 115
La chemioprevenzione del carcinoma mammario 115
Validation of the international prognostic index in working formulation group a low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo studio dei linfomi registry. 114
Utilità diagnostica della risonanza magnetica nucleare in onco-ematologia 111
Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) 111
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission 111
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form 110
Cancer Incidence in the Province of Modena. Cancer Incidence in Five Continents Vol.VII 110
Gli interferoni in terapia antineoplastica 109
La strategia terapeutica del GISL nei linfomi non-Hodgkin 109
La predisposizione genetica al cancro dell'ovaio. Individuazione e sorveglianza delle donne a rischio 108
PROMACE-CYTABOM VERSUS MACOP-B IN INTERMEDIATE AND HIGH-GRADE NHL - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL 103
Ruolo attuale della chemioterapia nel carcinoma transizionale della vescica muscolo-invasivo 101
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN AND CISPLATIN (M-VEC) IN PATIENTS WITH LOCALLY ADVANCED TRANSITIONAL BLADDER-CANCER 99
REGIMEN-RELATED LIVER TOXICITY IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 98
Free from failure survival in Hodgkin's disease. Long term analysis of 148 cases treated with a MOPP modified protocol 94
Emopoiesi extramidollare endotoracica in Morbo di Cooley dell'adulto 93
Immunohistochemical labeling index in breast cancer after in vivo administration of bromodeoxiuridine 86
Totale 10.350
Categoria #
all - tutte 34.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020948 0 0 0 0 0 0 375 153 139 59 120 102
2020/20211.296 124 34 190 74 116 78 115 155 78 127 80 125
2021/20221.294 28 159 111 129 40 105 72 64 149 73 223 141
2022/20231.403 123 130 109 125 180 238 18 131 173 24 58 94
2023/2024826 44 45 50 84 147 68 143 66 9 34 35 101
2024/20251.467 117 39 50 222 609 422 8 0 0 0 0 0
Totale 10.350